Subscribe for $1
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 77 of 100

This Is the Best Drugstore Stock to Own Now
Finance

This Is the Best Drugstore Stock to Own Now

By Chris Taylor
April 20, 2016
The Two Mercks Are Locking Horns in a Naming Trademark Spat
Health

The Two Mercks Are Locking Horns in a Naming Trademark Spat

By Sy Mukherjee
April 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca Is Eyeing This San Francisco Drugmaker

By Reuters
April 18, 2016
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
Tech

Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case

By Reuters
April 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant Talking to Investment Banks to Weigh Asset Sales

By Reuters
April 15, 2016
Inside of a Gilead Sciences Lab
Health

The FDA Wants Pharma to Ditch its Archaic Drug Making Process

By Sy Mukherjee
April 14, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
Health

U.S. Drug Spending Hits Record High (Again)

By Erika Fry
April 14, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Valeant’s CEO Just Avoided Contempt Charges From the U.S. Senate

By Reuters
April 13, 2016
Here’s Why Shares of This Hot Biopharma Are Jumping
Finance

Here’s Why Shares of This Hot Biopharma Are Jumping

By Lucinda Shen
April 13, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

Former Shkreli-Led Drug Developer Pledges Responsible Pricing

By Reuters
April 11, 2016
Apple Starts iPhone 6 Sales In Germany
Tech

A New Smartphone App Promises Help for Schizophrenia

By David Z. Morris
April 9, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
Finance

Intercept Pharma’s Shares Spike Before Falling On Key FDA Panel Backing

By Sy Mukherjee
April 8, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By Sy Mukherjee
April 7, 2016
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Health

A Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer

By Sy Mukherjee
April 7, 2016
Losses mount for U.S. stocks.
Finance

This Pharma Company’s Stock Is Popping for No Clear Reason

By Sy Mukherjee
April 7, 2016

Most Popular

  • Success
    Even with $850 billion to his name, Elon Musk admits ‘money can’t buy happiness.’ But billionaire Mark Cuban says it’s...
    By Preston Fore
  • Economy
    Elon Musk warns the U.S. is '1,000% going to go bankrupt' unless AI and robotics save the economy from crushing debt
    By Jason Ma
  • Success
    Gen Z Patriots quarterback Drake Maye still drives a 2015 pickup truck even after it broke down on the highway—despite...
    By Sasha Rogelberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.